<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36599092</PMID><DateCompleted><Year>2023</Year><Month>02</Month><Day>16</Day></DateCompleted><DateRevised><Year>2023</Year><Month>02</Month><Day>17</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2328-9503</ISSN><JournalIssue CitedMedium="Internet"><Volume>10</Volume><Issue>2</Issue><PubDate><Year>2023</Year><Month>Feb</Month></PubDate></JournalIssue><Title>Annals of clinical and translational neurology</Title><ISOAbbreviation>Ann Clin Transl Neurol</ISOAbbreviation></Journal><ArticleTitle>Cervical spinal cord atrophy in amyotrophic lateral sclerosis across disease stages.</ArticleTitle><Pagination><StartPage>213</StartPage><EndPage>224</EndPage><MedlinePgn>213-224</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1002/acn3.51712</ELocationID><Abstract><AbstractText Label="OBJECTIVE">Spinal cord degeneration is a hallmark of amyotrophic lateral sclerosis. The assessment of gray matter and white matter cervical spinal cord atrophy across clinical stages defined using the King's staging system could advance the understanding of amyotrophic lateral sclerosis progression.</AbstractText><AbstractText Label="METHODS">We assessed the in&#xa0;vivo spatial pattern of gray and white matter atrophy along cervical spinal cord (C2 to C6 segments) using 2D phase-sensitive inversion recovery imaging in a cohort of 44 amyotrophic lateral sclerosis patients, evaluating its change across the King's stages and the correlation with disability scored by the amyotrophic lateral sclerosis functional rating scale revised (ALSFRS-R) and disease duration. A mathematical model inferring the potential onset of cervical gray matter atrophy was developed.</AbstractText><AbstractText Label="RESULTS">In amyotrophic lateral sclerosis patients at King's stage 1, significant cervical spinal cord alterations were mainly identified in gray matter, whereas they involved both gray and white matter in patients at King's stage&#x2009;&#x2265;&#x2009;2. Gray and white matter areas correlated with clinical disability at all cervical segments. C3-C4 level was the segment showing early gray matter atrophy starting about 7 to 20&#xa0;months before symptom onset according to our model.</AbstractText><AbstractText Label="INTERPRETATION">Our findings suggest that cervical spinal cord atrophy spreads from gray to white matter across King's stages in amyotrophic lateral sclerosis, making spinal cord magnetic resonance imaging an in&#xa0;vivo assessment tool to measure the progression of the disease.</AbstractText><CopyrightInformation>&#xa9; 2023 The Authors. Annals of Clinical and Translational Neurology published by Wiley Periodicals LLC on behalf of American Neurological Association.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Nigri</LastName><ForeName>Anna</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-1197-5458</Identifier><AffiliationInfo><Affiliation>Neuroradiology Unit, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dalla Bella</LastName><ForeName>Eleonora</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>3rd Neurology Unit and Motor Neuron Disease Centre, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ferraro</LastName><ForeName>Stefania</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-5939-0459</Identifier><AffiliationInfo><Affiliation>Neuroradiology Unit, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Life Science and Technology, MOE Key Laboratory for Neuroinformation, University of Electronic Science and Technology of China, Chengdu, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Medina Carrion</LastName><ForeName>Jean Paul</ForeName><Initials>JP</Initials><Identifier Source="ORCID">0000-0002-6450-0202</Identifier><AffiliationInfo><Affiliation>Neuroradiology Unit, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Demichelis</LastName><ForeName>Greta</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Neuroradiology Unit, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bersano</LastName><ForeName>Enrica</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>3rd Neurology Unit and Motor Neuron Disease Centre, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medical Biotechnology and Translational Medicine, University of Milan, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Consonni</LastName><ForeName>Monica</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>3rd Neurology Unit and Motor Neuron Disease Centre, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bischof</LastName><ForeName>Antje</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0003-3862-5738</Identifier><AffiliationInfo><Affiliation>Weill Institute for Neurosciences, Department of Neurology, University of California, San Francisco, California, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology with Institute for Translational Neurology, University Hospital M&#xfc;nster, M&#xfc;nster, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stanziano</LastName><ForeName>Mario</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Neuroradiology Unit, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>ALS Centre, "Rita Levi Montalcini" Department of Neuroscience, University of Turin, Turin, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Palermo</LastName><ForeName>Sara</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Neuroradiology Unit, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lauria</LastName><ForeName>Giuseppe</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0001-9773-020X</Identifier><AffiliationInfo><Affiliation>3rd Neurology Unit and Motor Neuron Disease Centre, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medical Biotechnology and Translational Medicine, University of Milan, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bruzzone</LastName><ForeName>Maria Grazia</ForeName><Initials>MG</Initials><AffiliationInfo><Affiliation>Neuroradiology Unit, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Papinutto</LastName><ForeName>Nico</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Weill Institute for Neurosciences, Department of Neurology, University of California, San Francisco, California, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>01</Month><Day>04</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Ann Clin Transl Neurol</MedlineTA><NlmUniqueID>101623278</NlmUniqueID><ISSNLinking>2328-9503</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D066193" MajorTopicYN="Y">Cervical Cord</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D066128" MajorTopicYN="N">Gray Matter</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001284" MajorTopicYN="N">Atrophy</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>11</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>8</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>11</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>1</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>2</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>1</Month><Day>4</Day><Hour>15</Hour><Minute>32</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36599092</ArticleId><ArticleId IdType="pmc">PMC9930423</ArticleId><ArticleId IdType="doi">10.1002/acn3.51712</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Van Es MA, Hardiman O, Chio A, et&#xa0;al. Amyotrophic lateral sclerosis. Lancet. 2017;390:2084&#x2010;2098.</Citation><ArticleIdList><ArticleId IdType="pubmed">28552366</ArticleId></ArticleIdList></Reference><Reference><Citation>Chi&#xf2; A, Logroscino G, Traynor BJ, et&#xa0;al. Global epidemiology of amyotrophic lateral sclerosis: a systematic review of the published literature. Neuroepidemiology. 2013;41:118&#x2010;130.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4049265</ArticleId><ArticleId IdType="pubmed">23860588</ArticleId></ArticleIdList></Reference><Reference><Citation>Wijesekera LC, Leigh PN. Amyotrophic lateral sclerosis. Orphanet J Rare Dis. 2009;4:1&#x2010;22.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2656493</ArticleId><ArticleId IdType="pubmed">19192301</ArticleId></ArticleIdList></Reference><Reference><Citation>El Mendili MM, Querin G, Bede P, et&#xa0;al. Spinal cord imaging in amyotrophic lateral sclerosis: historical concepts &#x2013; novel techniques. Front Neurol. 2019;10:1&#x2010;11.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6474186</ArticleId><ArticleId IdType="pubmed">31031688</ArticleId></ArticleIdList></Reference><Reference><Citation>Cohen&#x2010;Adad J, El MMM, Morizot&#x2010;Koutlidis R, et&#xa0;al. Involvement of spinal sensory pathway in ALS and specificity of cord atrophy to lower motor neuron degeneration. Amyotroph Lateral Scler Front Degener. 2013;14:30&#x2010;38.</Citation><ArticleIdList><ArticleId IdType="pubmed">22881412</ArticleId></ArticleIdList></Reference><Reference><Citation>Branco LMT, De Albuquerque M, De Andrade HMT, et&#xa0;al. Spinal cord atrophy correlates with disease duration and severity in amyotrophic lateral sclerosis. Amyotroph Lateral Scler Front Degener. 2014;15:93&#x2010;97.</Citation><ArticleIdList><ArticleId IdType="pubmed">24219347</ArticleId></ArticleIdList></Reference><Reference><Citation>de Albuquerque M, Branco LMT, Rezende TJR, de Andrade HMT, Nucci A, Fran&#xe7;a MC Jr. Longitudinal evaluation of cerebral and spinal cord damage in amyotrophic lateral sclerosis. NeuroImage Clin. 2017;14:269&#x2010;276.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5294732</ArticleId><ArticleId IdType="pubmed">28203530</ArticleId></ArticleIdList></Reference><Reference><Citation>Paquin ME, Mendili MME, Gros C, et&#xa0;al. Spinal cord gray matter atrophy in amyotrophic lateral sclerosis. Am J Neuroradiol. 2018;39:184&#x2010;192.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7410702</ArticleId><ArticleId IdType="pubmed">29122760</ArticleId></ArticleIdList></Reference><Reference><Citation>Grolez G, Kyheng M, Lopes R, et&#xa0;al. MRI of the cervical spinal cord predicts respiratory dysfunction in ALS. Sci Rep. 2018;8:6&#x2010;11.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5789036</ArticleId><ArticleId IdType="pubmed">29379040</ArticleId></ArticleIdList></Reference><Reference><Citation>van der Burgh HK, Westeneng HJ, Meier JM, et&#xa0;al. Cross&#x2010;sectional and longitudinal assessment of the upper cervical spinal cord in motor neuron disease. NeuroImage Clin. 2019;24:101984.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6734179</ArticleId><ArticleId IdType="pubmed">31499409</ArticleId></ArticleIdList></Reference><Reference><Citation>Wimmer T, Schreiber F, Hensiek N, et&#xa0;al. The upper cervical spinal cord in ALS assessed by cross&#x2010;sectional and longitudinal 3T MRI. Sci Rep. 2020;10:1&#x2010;10.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7000761</ArticleId><ArticleId IdType="pubmed">32020025</ArticleId></ArticleIdList></Reference><Reference><Citation>Pisharady PK, Eberly LE, Cheong I, et&#xa0;al. Tract&#x2010;specific analysis improves sensitivity of spinal cord diffusion MRI to cross&#x2010;sectional and longitudinal changes in amyotrophic lateral sclerosis. Commun Biol. 2020;3:1&#x2010;13.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7351722</ArticleId><ArticleId IdType="pubmed">32651439</ArticleId></ArticleIdList></Reference><Reference><Citation>Barry RL, Torrado&#x2010;Carvajal A, Kirsch JE, et&#xa0;al. Selective atrophy of the cervical enlargement in whole spinal cord MRI of amyotrophic lateral sclerosis. NeuroImage Clin. 2022;36:103199.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9668597</ArticleId><ArticleId IdType="pubmed">36137496</ArticleId></ArticleIdList></Reference><Reference><Citation>Querin G, El Mendili MM, Lenglet T, et&#xa0;al. Spinal cord multi&#x2010;parametric magnetic resonance imaging for survival prediction in amyotrophic lateral sclerosis. Eur J Neurol. 2017;24:1040&#x2010;1046.</Citation><ArticleIdList><ArticleId IdType="pubmed">28586096</ArticleId></ArticleIdList></Reference><Reference><Citation>Agosta F, Rocca MA, Valsasina P, et&#xa0;al. A longitudinal diffusion tensor MRI study of the cervical cord and brain in amyotrophic lateral sclerosis patients. J Neurol Neurosurg Psychiatry. 2009;80:53&#x2010;55.</Citation><ArticleIdList><ArticleId IdType="pubmed">18931009</ArticleId></ArticleIdList></Reference><Reference><Citation>El Mendili MM, Cohen&#x2010;Adad J, Pelegrini&#x2010;Issac M, et&#xa0;al. Multi&#x2010;parametric spinal cord MRI as potential progression marker in amyotrophic lateral sclerosis. PLoS One. 2014;9:1&#x2010;7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3995720</ArticleId><ArticleId IdType="pubmed">24755826</ArticleId></ArticleIdList></Reference><Reference><Citation>Rasoanandrianina H, Grapperon AM, Taso M, et&#xa0;al. Region&#x2010;specific impairment of the cervical spinal cord (SC) in amyotrophic lateral sclerosis: a preliminary study using SC templates and quantitative MRI (diffusion tensor imaging/inhomogeneous magnetization transfer). NMR Biomed. 2017;30:1&#x2010;13.</Citation><ArticleIdList><ArticleId IdType="pubmed">28926131</ArticleId></ArticleIdList></Reference><Reference><Citation>Olney NT, Bischof A, Rosen H, et&#xa0;al. Measurement of spinal cord atrophy using phase sensitive inversion recovery (PSIR) imaging in motor neuron disease. PLoS One. 2018;13:1&#x2010;15.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6264489</ArticleId><ArticleId IdType="pubmed">30496320</ArticleId></ArticleIdList></Reference><Reference><Citation>Papinutto N, Henry RG. Evaluation of intra&#x2010; and Interscanner reliability of MRI protocols for spinal cord gray matter and Total cross&#x2010;sectional area measurements. J Magn Reson Imaging. 2019;49:1078&#x2010;1090.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6620602</ArticleId><ArticleId IdType="pubmed">30198209</ArticleId></ArticleIdList></Reference><Reference><Citation>Papinutto N, Schlaeger R, Panara V, et&#xa0;al. 2D phase sensitive inversion recovery imaging to measure in&#x2010; vivo spinal cord gray and white matter areas in clinically feasible acquisition times. J Magn Reson Imaging. 2015;42:698&#x2010;708.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5953416</ArticleId><ArticleId IdType="pubmed">25483607</ArticleId></ArticleIdList></Reference><Reference><Citation>Schlaeger R, Papinutto N, Panara V, et&#xa0;al. Spinal cord gray matter atrophy correlates with multiple sclerosis disability. Ann Neurol. 2014;76:568&#x2010;580.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5316412</ArticleId><ArticleId IdType="pubmed">25087920</ArticleId></ArticleIdList></Reference><Reference><Citation>Roche JC, Rojas&#x2010;Garcia R, Scott KM, et&#xa0;al. A proposed staging system for amyotrophic lateral sclerosis. Brain. 2012;135:847&#x2010;852.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3286327</ArticleId><ArticleId IdType="pubmed">22271664</ArticleId></ArticleIdList></Reference><Reference><Citation>Brooks BR, Miller RG, Swash M, Munsat TL. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler. 2000;1:293&#x2010;299.</Citation><ArticleIdList><ArticleId IdType="pubmed">11464847</ArticleId></ArticleIdList></Reference><Reference><Citation>Cedarbaum JM, Stambler N, Malta E, et&#xa0;al. The ALSFRS&#x2010;R: a revised ALS functional rating scale that incorporates assessments of respiratory function. J Neurol Sci. 1999;169:13&#x2010;21.</Citation><ArticleIdList><ArticleId IdType="pubmed">10540002</ArticleId></ArticleIdList></Reference><Reference><Citation>Bakker LA, Schr&#xf6;der CD, Tan HHG, et&#xa0;al. Development and assessment of the inter&#x2010;rater and intra&#x2010;rater reproducibility of a self&#x2010;administration version of the ALSFRS&#x2010;R. J Neurol Neurosurg Psychiatry. 2020;91:75&#x2010;81.</Citation><ArticleIdList><ArticleId IdType="pubmed">31558653</ArticleId></ArticleIdList></Reference><Reference><Citation>Kimura F, Fujimura C, Ishida S, et&#xa0;al. Progression rate of ALSFRS&#x2010;R at time of diagnosis predicts survival time in ALS. Neurology. 2006;38:265&#x2010;267.</Citation><ArticleIdList><ArticleId IdType="pubmed">16434671</ArticleId></ArticleIdList></Reference><Reference><Citation>Fang T, Al Khleifat A, Stahl DR, et&#xa0;al. Comparison of the King's and MiToS staging systems for ALS. Amyotroph Lateral Scler Front Degener. 2017;18:227&#x2010;232.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5425622</ArticleId><ArticleId IdType="pubmed">28054828</ArticleId></ArticleIdList></Reference><Reference><Citation>Papinutto N, Asteggiano C, Bischof A, et&#xa0;al. Intersubject variability and normalization strategies for spinal cord total cross&#x2010;sectional and gray matter areas. J Neuroimaging. 2020;30:110&#x2010;118.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7153493</ArticleId><ArticleId IdType="pubmed">31571307</ArticleId></ArticleIdList></Reference><Reference><Citation>Papinutto N, Cordano C, Asteggiano C, et&#xa0;al. MRI measurement of upper cervical spinal cord cross&#x2010;sectional area in children. J Neuroimaging. 2020;30:598&#x2010;602.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7530010</ArticleId><ArticleId IdType="pubmed">32639671</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith SM, Zhang Y, Jenkinson M, et&#xa0;al. Accurate, robust, and automated longitudinal and cross&#x2010;sectional brain change analysis. Neuroimage. 2002;17:479&#x2010;489.</Citation><ArticleIdList><ArticleId IdType="pubmed">12482100</ArticleId></ArticleIdList></Reference><Reference><Citation>Brettschneider J, Arai K, Del Tredici K, et&#xa0;al. TDP&#x2010;43 pathology and neuronal loss in amyotrophic lateral sclerosis spinal cord. Acta Neuropathol. 2014;128:423&#x2010;437.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4384652</ArticleId><ArticleId IdType="pubmed">24916269</ArticleId></ArticleIdList></Reference><Reference><Citation>Labra J, Menon P, Byth K, Morrison S, Vucic S. Rate of disease progression: a prognostic biomarker in ALS. J Neurol Neurosurg Psychiatry. 2016;87:628&#x2010;632.</Citation><ArticleIdList><ArticleId IdType="pubmed">26152368</ArticleId></ArticleIdList></Reference><Reference><Citation>Schlaeger R, Papinutto N, Zhu AH, et&#xa0;al. Association between thoracic spinal cord gray matter atrophy and disability in multiple sclerosis. JAMA Neurol. 2015;72:897&#x2010;904.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6002864</ArticleId><ArticleId IdType="pubmed">26053119</ArticleId></ArticleIdList></Reference><Reference><Citation>Yiannakas MC, Kakar P, Hoy LR, et&#xa0;al. The use of the lumbosacral enlargement as an intrinsic imaging biomarker: feasibility of grey matter and white matter cross&#x2010;sectional area measurements using MRI at 3T. PLoS One. 9. Epub ahead of print 2014. doi:10.1371/journal.pone.0105544</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0105544</ArticleId><ArticleId IdType="pmc">PMC4149374</ArticleId><ArticleId IdType="pubmed">25170763</ArticleId></ArticleIdList></Reference><Reference><Citation>De Leener B, L&#xe9;vy S, Dupont SM, et&#xa0;al. SCT: spinal cord toolbox, an open&#x2010;source software for processing spinal cord MRI data. Neuroimage. 2017;145:24&#x2010;43.</Citation><ArticleIdList><ArticleId IdType="pubmed">27720818</ArticleId></ArticleIdList></Reference><Reference><Citation>Datta E, Papinutto N, Schlaeger R, Zhu A, Carballido&#x2010;Gamio J, Henry RG. Gray matter segmentation of the spinal cord with active contours in MR images. Neuroimage. 2017;147:788&#x2010;799.</Citation><ArticleIdList><ArticleId IdType="pubmed">27495383</ArticleId></ArticleIdList></Reference><Reference><Citation>Prados F, Ashburner J, Blaiotta C, et&#xa0;al. Spinal cord grey matter segmentation challenge. Neuroimage. 2017;152:312&#x2010;329.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5440179</ArticleId><ArticleId IdType="pubmed">28286318</ArticleId></ArticleIdList></Reference><Reference><Citation>Perone CS, Calabrese E, Cohen&#x2010;Adad J. Spinal cord gray matter segmentation using deep dilated convolutions. Sci Rep. 2018;8:1&#x2010;13.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5899127</ArticleId><ArticleId IdType="pubmed">29654236</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>